Form 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

  1. KEY INFORMATION
Name of person dealing (Note 1) Invesco Ltd.
Company dealt in Allergan PLC
Class of relevant security to which the dealings being disclosed relate (Note 2) Ordinary Shares IE00BY9D5467
Date of dealing 28-06-2019
  1. INTERESTS AND SHORT POSITIONS
     
  2. Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
  Long Short
  Number   (%) Number   (%)
(1) Relevant securities 3,232,795*   0.986%   
(2) Derivatives (other than options)    
(3) Options and agreements to purchase/sell    
Total 3,232,795*   0.986%   

*The change of 7 shares in holdings since the previous disclosure filed on 28-06-2019 is due to the transfer out of a discretionary holding.

  1. Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: Long Short
  Number   (%) Number   (%)
(1) Relevant securities    
 

(2) Derivatives (other than options)		    
 

(3) Options and agreements to purchase/sell		    
Total    


  1. DEALINGS (Note 4)
     
  2. Purchases and sales
 

Purchase/sale		  

Number of relevant securities		  

Price per unit (Note 5)
Sell 85 166.10 USD
Sell 124,462 167.32 USD
Sell 6,480 167.43 USD
Buy 2,843 167.43 USD
Buy 143 166.10 USD
Sell 57  167.24 USD
  1. Derivatives transactions (other than options transactions)
Product name,

e.g. CFD		 Nature of transaction

(Note 6)		 Number of relevant securities

(Note 7)		 Price per unit

(Note 5)
       
  1. Options transactions in respect of existing relevant securities
  1. Writing, selling, purchasing or varying
Product name,
e.g. call option		 Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
             
  1. Exercising
Product name,

e.g. call option		 Number of securities Exercise price per unit (Note 5)
     
  1. Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction

(Note 8)		 Details Price per unit

(if applicable) (Note 5)
     


Is a Supplemental Form 8 attached? (Note 9)                                            YES/NO

Date of disclosure 01-07-2019
Contact name Sam Edwards
Telephone number 01491 416 381
If a connected EFM, name of offeree/offeror with which connected N/A
If a connected EFM, state nature of connection (Note 10)